Enlaza

Enlaza company information, Employees & Contact Information

Explore related pages

Enlaza email format Enlaza management contacts

Related company profiles:

A community of over 2,000 founders, investors, corporate leaders, and ecosystem builders taking action to close the gender gap in the tech-for-good startup ecosystem. Our network spans 10 countries: Mexico, Peru, Colombia, Ecuador, Bolivia, Guatemala, Spain, USA (Miami), Argentina, and Brazil. Join us!

Company Details

Employees
14
Founded
-
Industry
Civic And Social Organizations
NAICS
Civic and Social Organizations
Website
http://www.enlaza.org/
Keywords
WIAN | The Women in International Affairs Network.
Competitors
Mexico Business, Chany Ventures, Holberton Coderise, WIAN | The Women in International Affairs Network, EWA Capital, Pomona Impact, Invariantes Fund, Seedstars, Catalyst Now, Mujeres Invirtiendo.
Looking for a particular Enlaza employee's phone or email?

Enlaza Questions

News

Editor’s pick: Enlaza Therapeutics - Nature

Editor’s pick: Enlaza Therapeutics Nature

Vertex locks on to $2B covalent biologics deal with Enlaza - FirstWord Pharma

Vertex locks on to $2B covalent biologics deal with Enlaza FirstWord Pharma

Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases - Business Wire

Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases Business Wire

Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact - BioSpace

Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact BioSpace

Vertex forges $2B-plus alliance with Enlaza to create new autoimmune drugs, improve conditioning methods - Fierce Biotech

Vertex forges $2B-plus alliance with Enlaza to create new autoimmune drugs, improve conditioning methods Fierce Biotech

Enlaza Therapeutics Forms $2.4 Billion Collaboration with Vertex Pharmaceuticals - Pharmaceutical Executive

Enlaza Therapeutics Forms $2.4 Billion Collaboration with Vertex Pharmaceuticals Pharmaceutical Executive

Vertex enlists Enlaza for gene therapy conditioning and autoimmune disease pact - Endpoints News

Vertex enlists Enlaza for gene therapy conditioning and autoimmune disease pact Endpoints News

Vertex teams with Enlaza to expand gene therapy options - The Pharma Letter

Vertex teams with Enlaza to expand gene therapy options The Pharma Letter

Vertex Pharma, Enlaza sign R&D pact worth up to $2B plus equity - Seeking Alpha

Vertex Pharma, Enlaza sign R&D pact worth up to $2B plus equity Seeking Alpha

Enlaza takes the helm in a $2B+ Vertex deal - BioWorld MedTech

Enlaza takes the helm in a $2B+ Vertex deal BioWorld MedTech

Enlaza Therapeutics - ACS Publications

Enlaza Therapeutics ACS Publications

Enlaza Strengthening Program: an Opportunity to Strengthen Ourselves as a Civil Society - Dejusticia

Enlaza Strengthening Program: an Opportunity to Strengthen Ourselves as a Civil Society Dejusticia

Firm Advises Enlaza on IP Matters Related to Multi-Target Drug Discovery Collaboration with Vertex Pharmaceuticals - Wilson Sonsini

Firm Advises Enlaza on IP Matters Related to Multi-Target Drug Discovery Collaboration with Vertex Pharmaceuticals Wilson Sonsini

10 Start-Ups to Watch 2024: Enlaza Therapeutics marries covalent and biologic drugs - Chemical & Engineering News

10 Start-Ups to Watch 2024: Enlaza Therapeutics marries covalent and biologic drugs Chemical & Engineering News

Enlaza gets JP Morgan, Regeneron backing for covalent biologics - BioPharma Dive

Enlaza gets JP Morgan, Regeneron backing for covalent biologics BioPharma Dive

Wilson Sonsini Advises Enlaza Therapeutics on IP Matters Related to $100 Million Series A - Wilson Sonsini

Wilson Sonsini Advises Enlaza Therapeutics on IP Matters Related to $100 Million Series A Wilson Sonsini

Enlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private Capital - Business Wire

Enlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private Capital Business Wire

Enlaza Raises $100M in Series A Financing Led by JP Morgan’s Life Sciences Group - BioSpace

Enlaza Raises $100M in Series A Financing Led by JP Morgan’s Life Sciences Group BioSpace

Newly launched Enlaza aims to bring covalency to biologics - Chemical & Engineering News

Newly launched Enlaza aims to bring covalency to biologics Chemical & Engineering News

Enlaza Nets $100M to Advance Covalent Biologics Platform - Inside Precision Medicine

Enlaza Nets $100M to Advance Covalent Biologics Platform Inside Precision Medicine

Enlaza: Creating covalent biologics using engineered amino acids - BioCentury

Enlaza: Creating covalent biologics using engineered amino acids BioCentury

Enlaza Therapeutics Appoints Jeffrey Leiden, M.D., Ph.D., as a Key Advisor - Business Wire

Enlaza Therapeutics Appoints Jeffrey Leiden, M.D., Ph.D., as a Key Advisor Business Wire

White Space for Drug Discovery: Enlaza Therapeutics Grabs $61 Million to Industrialize Covalent Biologics: - Mary Ann Liebert, Inc.

White Space for Drug Discovery: Enlaza Therapeutics Grabs $61 Million to Industrialize Covalent Biologics: Mary Ann Liebert, Inc.

Enlaza raises $100M to lock up ‘irreversible’ protein binding - FirstWord Pharma

Enlaza raises $100M to lock up ‘irreversible’ protein binding FirstWord Pharma

Enlaza Therapeutics secures $100m in Series A funding - Pharmaceutical Technology

Enlaza Therapeutics secures $100m in Series A funding Pharmaceutical Technology

Enlaza Snags $61M Seed Round - San Diego Business Journal

Enlaza Snags $61M Seed Round San Diego Business Journal

Enlaza Therapeutics Launches with $61 Million Financing to Advance the First Covalent Biologic Therapeutic Platform - Business Wire

Enlaza Therapeutics Launches with $61 Million Financing to Advance the First Covalent Biologic Therapeutic Platform Business Wire

A San Diego startup sees covalent biologics as the next frontier in cancer drugs - BioPharma Dive

A San Diego startup sees covalent biologics as the next frontier in cancer drugs BioPharma Dive

Fierce Biotech Fundraising Tracker: Enlaza launches with $61M; Enveda brings in $68M - Fierce Biotech

Fierce Biotech Fundraising Tracker: Enlaza launches with $61M; Enveda brings in $68M Fierce Biotech

Bicycle ‘Sharrows,’ A Denver Invention, Now Under Researchers’ Scrutiny - Colorado Public Radio

Bicycle ‘Sharrows,’ A Denver Invention, Now Under Researchers’ Scrutiny Colorado Public Radio

Companies like Enlaza

Mexico Business logo - Similar company to Enlaza

Mexico Business

60
WIAN | The Women in International Affairs Network logo - Similar company to Enlaza

Wian | The Women In ...

11
Invariantes Fund logo - Similar company to Enlaza

Invariantes Fund

5
Catalyst Now logo - Similar company to Enlaza

Catalyst Now

296
Holberton Coderise logo - Similar company to Enlaza

Holberton Coderise

14
EWA Capital logo - Similar company to Enlaza

Ewa Capital

9
Pomona Impact logo - Similar company to Enlaza

Pomona Impact

15
Mujeres Invirtiendo logo - Similar company to Enlaza

Mujeres Invirtiendo

99
Seedstars logo - Similar company to Enlaza

Seedstars

231
Chany Ventures logo - Similar company to Enlaza

Chany Ventures

7

Top Enlaza Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant